NCT00904904

Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being conducted to show that indomethacin is at least as effective as ketorolac for the prevention of ocular inflammation following cataract surgery.

Conditions

• Cataract
• Inflammation

Interventions

Type	Name	Description
DRUG	Indomethacin ophthalmic solution	Indomethacin 0.1% eye drops administered pre-cataract surgery and for 4 weeks post-cataract surgery
DRUG	Ketorolac Ophthalmic Solution	Ketorolac 0.5% eye drops administered pre-cataract surgery and 4 weeks post-cataract surgery

Timeline

• Start date: 2008-04-01
• Primary completion: 2009-06-01
• Completion: 2009-09-01
• First posted: 2009-05-20
• Last updated: 2012-08-13

Locations

1 site across 1 country: Germany